On the other hand, although inhibition of PGRMC1-mediated EGFR signaling by GL derivatives contributes significantly to their suppression of cancer growth and chemotherapeutic resistance, PGRMC1 is known to regulate various functional pathways, including the insulin response and heme biosynthesis pathways [64,65]. The gene discussed is PGRMC1; the disease is cancer.